BPC-157: Patient Information & Safety Notes
Also known as PL 14736
Other names: body-protecting-compound-157, pl-14736
BPC-157 is a synthetic pentadecapeptide studied in laboratory and animal models for possible effects on tissue and gastrointestinal pathways. It is not approved by the FDA for any human indication.
In plain language
What BPC-157 is used for
- Studied in preclinical models for effects on tissue and gastrointestinal pathways
Taking this medicine
How it is administered
- Subcutaneous injection
- Oral capsule
Read before you decide
Risks and precautions
Risks and warnings
- Injection site irritation
- Human safety profile not established in large clinical trials
Who should not take it
- Pregnancy or breastfeeding (insufficient safety data)
Common questions
Patient questions
Is BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved for any indication. It has been studied in animal models but has not completed human clinical trials demonstrating safety and efficacy. It is a research compound. Discuss any injury recovery or GI concerns with a licensed provider who can recommend evidence-based treatments.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.